| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |